Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation
Abstract Background Cardiac Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation plays a critical role in cardiomyocyte (CM) apoptosis and arrhythmia. Functional ATP-sensitive potassium (KATP) channels are essential for cardiac protection during ischemia. In cultured CMs, L5 low-density l...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-020-01368-7 |
id |
doaj-3aa2b3b2282f4b0abf2094735a47f5d3 |
---|---|
record_format |
Article |
spelling |
doaj-3aa2b3b2282f4b0abf2094735a47f5d32020-11-25T03:49:14ZengBMCLipids in Health and Disease1476-511X2020-08-0119111010.1186/s12944-020-01368-7Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activationYanzhuo Ma0Nancy Cheng1Junping Sun2Jonathan Xuhai Lu3Shahrzad Abbasi4Geru Wu5An-Sheng Lee6Tatsuya Sawamura7Jie Cheng8Chu-Huang Chen9Yutao Xi10Department of Cardiology, Bethune International Peace HospitalCardiac Electrophysiology Research Laboratory, Texas Heart InstituteCardiac Electrophysiology Research Laboratory, Texas Heart InstituteVascular and Medicinal Research, Texas Heart InstituteMolecular Cardiology Research, Texas Heart InstituteCardiac Electrophysiology Research Laboratory, Texas Heart InstituteDepartment of Medicine, Mackay Medical CollegeDepartment of Life Innovation, Institute for Biomedical Sciences, Shinshu UniversityCardiac Electrophysiology Research Laboratory, Texas Heart InstituteVascular and Medicinal Research, Texas Heart InstituteDepartment of Cardiology, Bethune International Peace HospitalAbstract Background Cardiac Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation plays a critical role in cardiomyocyte (CM) apoptosis and arrhythmia. Functional ATP-sensitive potassium (KATP) channels are essential for cardiac protection during ischemia. In cultured CMs, L5 low-density lipoprotein (LDL) induces apoptosis and QTc prolongation. L5 is a highly electronegative and atherogenic aberrant form of LDL, and its levels are significantly higher in patients with cardiovascular-related diseases. Here, the role of L5 in cardiac injury was studied by evaluating the effects of L5 on CaMKII activity and KATP channel physiology in CMs. Methods Cultured neonatal rat CMs (NRCMs) were treated with a moderate concentration (ie, 7.5 μg/mL) of L5 or L1 (the least electronegative LDL subfraction). NRCMs were examined for apoptosis and viability, CaMKII activity, and the expression of phosphorylated CaMKIIδ and NOX2/gp91phox. The function of KATP and action potentials (APs) was analyzed by using the patch-clamp technique. Results In NRCMs, L5 but not L1 significantly induced cell apoptosis and reduced cell viability. Furthermore, L5 decreased Kir6.2 expression by more than 50%. Patch-clamp analysis showed that L5 reduced the KATP current (IKATP) density induced by pinacidil, a KATP opener. The partial recovery of the inward potassium current during pinacidil washout was susceptible to subsequent inhibition by the IKATP blocker glibenclamide. Suppression of IKATP by L5 significantly prolonged the AP duration. L5 also significantly increased the activity of CaMKII, the phosphorylation of CaMKIIδ, and the expression of NOX2/gp91phox. L5-induced apoptosis was prevented by the addition of the CaMKII inhibitor KN93 and the reactive oxygen species scavenger Mn (III)TBAP. Conclusions L5 but not L1 induces CM damage through the activation of the CaMKII pathway and increases arrhythmogenicity in CMs by modulating the AP duration. These results help to explain the harmful effects of L5 in cardiovascular-related disease.http://link.springer.com/article/10.1186/s12944-020-01368-7Action potentialATP-sensitive potassiumCa2+/calmodulin-dependent protein kinase IICardiomyocytesElectronegative low-density lipoprotein |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yanzhuo Ma Nancy Cheng Junping Sun Jonathan Xuhai Lu Shahrzad Abbasi Geru Wu An-Sheng Lee Tatsuya Sawamura Jie Cheng Chu-Huang Chen Yutao Xi |
spellingShingle |
Yanzhuo Ma Nancy Cheng Junping Sun Jonathan Xuhai Lu Shahrzad Abbasi Geru Wu An-Sheng Lee Tatsuya Sawamura Jie Cheng Chu-Huang Chen Yutao Xi Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation Lipids in Health and Disease Action potential ATP-sensitive potassium Ca2+/calmodulin-dependent protein kinase II Cardiomyocytes Electronegative low-density lipoprotein |
author_facet |
Yanzhuo Ma Nancy Cheng Junping Sun Jonathan Xuhai Lu Shahrzad Abbasi Geru Wu An-Sheng Lee Tatsuya Sawamura Jie Cheng Chu-Huang Chen Yutao Xi |
author_sort |
Yanzhuo Ma |
title |
Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation |
title_short |
Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation |
title_full |
Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation |
title_fullStr |
Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation |
title_full_unstemmed |
Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation |
title_sort |
atherogenic l5 ldl induces cardiomyocyte apoptosis and inhibits katp channels through camkii activation |
publisher |
BMC |
series |
Lipids in Health and Disease |
issn |
1476-511X |
publishDate |
2020-08-01 |
description |
Abstract Background Cardiac Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation plays a critical role in cardiomyocyte (CM) apoptosis and arrhythmia. Functional ATP-sensitive potassium (KATP) channels are essential for cardiac protection during ischemia. In cultured CMs, L5 low-density lipoprotein (LDL) induces apoptosis and QTc prolongation. L5 is a highly electronegative and atherogenic aberrant form of LDL, and its levels are significantly higher in patients with cardiovascular-related diseases. Here, the role of L5 in cardiac injury was studied by evaluating the effects of L5 on CaMKII activity and KATP channel physiology in CMs. Methods Cultured neonatal rat CMs (NRCMs) were treated with a moderate concentration (ie, 7.5 μg/mL) of L5 or L1 (the least electronegative LDL subfraction). NRCMs were examined for apoptosis and viability, CaMKII activity, and the expression of phosphorylated CaMKIIδ and NOX2/gp91phox. The function of KATP and action potentials (APs) was analyzed by using the patch-clamp technique. Results In NRCMs, L5 but not L1 significantly induced cell apoptosis and reduced cell viability. Furthermore, L5 decreased Kir6.2 expression by more than 50%. Patch-clamp analysis showed that L5 reduced the KATP current (IKATP) density induced by pinacidil, a KATP opener. The partial recovery of the inward potassium current during pinacidil washout was susceptible to subsequent inhibition by the IKATP blocker glibenclamide. Suppression of IKATP by L5 significantly prolonged the AP duration. L5 also significantly increased the activity of CaMKII, the phosphorylation of CaMKIIδ, and the expression of NOX2/gp91phox. L5-induced apoptosis was prevented by the addition of the CaMKII inhibitor KN93 and the reactive oxygen species scavenger Mn (III)TBAP. Conclusions L5 but not L1 induces CM damage through the activation of the CaMKII pathway and increases arrhythmogenicity in CMs by modulating the AP duration. These results help to explain the harmful effects of L5 in cardiovascular-related disease. |
topic |
Action potential ATP-sensitive potassium Ca2+/calmodulin-dependent protein kinase II Cardiomyocytes Electronegative low-density lipoprotein |
url |
http://link.springer.com/article/10.1186/s12944-020-01368-7 |
work_keys_str_mv |
AT yanzhuoma atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT nancycheng atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT junpingsun atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT jonathanxuhailu atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT shahrzadabbasi atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT geruwu atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT anshenglee atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT tatsuyasawamura atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT jiecheng atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT chuhuangchen atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation AT yutaoxi atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation |
_version_ |
1724496512537329664 |